Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura) has announced that the European Commission has granted Marketing Authorization for PADCEV™ (enfortumab vedotin, an antibody-drug conjugate [ADC]) in combination with KEYTRUDA® (pembrolizumab, a PD-1 inhibitor) for the first-line treatment…
Merck, a leading science and technology company, has announced that the first patient has been dosed in the Phase III MyClad trial (NCT06463587). This trial aims to evaluate the efficacy and safety of oral cladribine for treating generalized Myasthenia Gravis…
GSK plc (LSE/NYSE: GSK) has announced that the European Commission has authorized Arexvy, a recombinant adjuvanted respiratory syncytial virus (RSV) vaccine, for active immunization to prevent lower respiratory tract disease (LRTD) caused by RSV in adults aged 50-59 who are…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved PiaSky® (crovalimab), a novel monoclonal antibody designed to inhibit the complement protein C5, for the treatment of adults and adolescents (12 years and older, weighing at…
Hinge Health and Midi Health have announced a partnership aimed at addressing the significant healthcare gap for women undergoing menopause. This collaboration merges Hinge Health’s expertise in movement-based support for menopause with Midi Health’s virtual care clinic, targeting the broad…
MedImpact Healthcare Systems, Inc., the largest independent provider of health solutions, technology, and pharmacy benefit services in the U.S., announced today the expansion of access to Humira biosimilars—Simlandi and adalimumab-adaz—for new patients needing treatment for inflammatory conditions like Crohn’s disease…
Avanzanite Bioscience BV, a specialty pharmaceutical company in the development stage, has announced that the European Commission (EC) has granted marketing authorization for AKANTIOR® (polihexanide), a treatment for acanthamoeba keratitis (AK) in adults and children aged 12 and older. This…
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the European Commission (EC) has granted approval for Ordspono™ (odronextamab) to treat adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL) who have undergone…
Bristol Myers Squibb (NYSE: BMY) has announced that it will present research findings from its comprehensive cardiovascular portfolio at the European Society of Cardiology (ESC) Congress, scheduled for August 30 – September 2, 2024, in London, England. The presentations will…
ADVI Health is excited to announce its acquisition of Partnership for Health Analytic Research (PHAR), a leading consultancy specializing in global health technology assessment (HTA) and health economics and outcomes research (HEOR). Known for delivering impactful, data-driven insights to major…
In 2017, Maria Morais began experiencing severe abdominal pain, which led to gall bladder surgery. However, when the procedure failed to alleviate her discomfort, follow-up tests revealed alarmingly high liver enzyme levels. As a registered nurse, Maria recognized that something…
Aetna Better Health® of Illinois, a CVS Health® company (NYSE: CVS), has announced a generous community investment of $100,000 to the Safer Foundation. This funding aims to assist in housing unhoused families in Chicago. To date, Aetna’s investment has enabled…
